Pleiotropic potential of dehydroxymethylepoxyquinomicin for NF-κB suppression via reactive oxygen species and unfolded protein response

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6559-6569

  Nakajima, Shotaro ^a   Kato, Hironori ^a   Gu, Liubao ^a,b   Takahashi, Shuhei ^a   Johno, Hisashi ^a   Umezawa, Kazuo ^c   Kitamura, Masanori ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b BEIJING HOSPITAL   (China)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; DEHYDROXYMETHYLEPOXYQUINOMICIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; RAT; UNFOLDED PROTEIN RESPONSE;

ANIMALS; BENZAMIDES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CYCLOHEXANONES; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSFECTION; UNFOLDED PROTEIN RESPONSE;

EID: 84879122483     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300155     Document Type: Article

References (80)

1. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18: 2195-2224.
2. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071. (Pubitemid 27163860)
3. Tak, P. P., and G. S. Firestein. 2001. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107: 7-11. (Pubitemid 32047405)
4. Newton, K., M. L. Matsumoto, I. E. Wertz, D. S. Kirkpatrick, J. R. Lill, J. Tan, D. Dugger, N. Gordon, S. S. Sidhu, F. A. Fellouse, et al. 2008. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134: 668-678.
5. Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, and Z. J. Chen. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
6. Conze, D. B., C. J. Wu, J. A. Thomas, A. Landstrom, and J. D. Ashwell. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and Toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 28: 3538-3547. (Pubitemid 351657114)
7. Kanayama, A., R. B. Seth, L. Sun, C. K. Ea, M. Hong, A. Shaito, Y. H. Chiu, L. Deng, and Z. J. Chen. 2004. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15: 535-548. (Pubitemid 39141781)
8. Sakurai, H., N. Shigemori, K. Hasegawa, and T. Sugita. 1998. TGF-β-activated kinase 1 stimulates NF-κB activation by an NF-κB-inducing kinase-independent mechanism. Biochem. Biophys. Res. Commun. 243: 545-549. (Pubitemid 28414061)
9. Viatour, P., M. P. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30: 43-52. (Pubitemid 40093740)
10. Matsumoto, N., A. Ariga, S. To-e, H. Nakamura, N. Agata, S. Hirano, J. Inoue, and K. Umezawa. 2000. Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C. Bioorg. Med. Chem. Lett. 10: 865-869. (Pubitemid 30301582)
11. Yamamoto, M., R. Horie, M. Takeiri, I. Kozawa, and K. Umezawa. 2008. Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues. J. Med. Chem. 51: 5780-5788.
12. Kubota, T., M. Hoshino, K. Aoki, K. Ohya, Y. Komano, T. Nanki, N. Miyasaka, and K. Umezawa. 2007. NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Arthritis Res. Ther. 9: R97.
13. Iwata, D., N. Kitaichi, A. Miyazaki, K. Iwabuchi, K. Yoshida, K. Namba, M. Ozaki, S. Ohno, K. Umezawa, K. Yamashita, et al. 2010. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-κB inhibitor dehydroxy methyl epoxyquinomicin in mice. Invest. Ophthalmol. Vis. Sci. 51: 2077-2084.
14. Miyajima, A., T. Kosaka, K. Seta, T. Asano, K. Umezawa, and M. Hayakawa. 2003. Novel nuclear factor κ B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J. Urol. 169: 1559-1563. (Pubitemid 36323844)
15. Kosaka, T., A. Miyajima, E. Kikuchi, Y. Horiguchi, K. Umezawa, T. Ohigashi, J. Nakashima, T. Asano, and M. Oya. 2008. The novel NF-κB activation inhibitor dehydroxymethylepoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats. Nephron. Exp. Nephrol. 110: e17-e24.
16. Kikuchi, E., Y. Horiguchi, J. Nakashima, K. Kuroda, M. Oya, T. Ohigashi, N. Takahashi, Y. Shima, K. Umezawa, and M. Murai. 2003. Suppression of hormone-refractory prostate cancer by a novel nuclear factor κB inhibitor in nude mice. Cancer Res. 63: 107-110. (Pubitemid 36070427)
17. Matsumoto, G., J. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, and K. Umezawa. 2005. Targeting of nuclear factor κB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Clin. Cancer Res. 11: 1287-1293. (Pubitemid 40175782)
18. Lampiasi, N., A. Azzolina, N. D'Alessandro, K. Umezawa, J. A. McCubrey, G. Montalto, and M. Cervello. 2009. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Mol. Pharmacol. 76: 290-300.
19. Gloire, G., S. Legrand-Poels, and J. Piette. 2006. NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72: 1493-1505. (Pubitemid 44666727)
20. Morgan, M. J., and Z. G. Liu. 2011. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 21: 103-115.
21. Wu, M., Q. Bian, Y. Liu, A. F. Fernandes, A. Taylor, P. Pereira, and F. Shang. 2009. Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome. Free Radic. Biol. Med. 46: 62-69.
22. Loukili, N., N. Rosenblatt-Velin, J. Rolli, S. Levrand, F. Feihl, B. Waeber, P. Pacher, and L. Liaudet. 2010. Oxidants positively or negatively regulate nuclear factor κB in a context-dependent manner. J. Biol. Chem. 285: 15746-15752.
23. Suzuki, Y., C. Sugiyama, O. Ohno, and K. Umezawa. 2004. Preparation and biological activities of optically active dehydroxymethylepoxyquinomicin, a novel NF-κB inhibitor. Tetrahedron 60: 7061-7066. (Pubitemid 38942932)
24. Okazaki, T., S. Sakon, T. Sasazuki, H. Sakurai, T. Doi, H. Yagita, K. Okumura, and H. Nakano. 2003. Phosphorylation of serine 276 is essential for p65 NF-κB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300: 807-812. (Pubitemid 36259833)
25. Ozawa, K., K. Kuwabara, M. Tamatani, K. Takatsuji, Y. Tsukamoto, S. Kaneda, H. Yanagi, D. M. Stern, Y. Eguchi, Y. Tsujimoto, et al. 1999. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 274: 6397-6404. (Pubitemid 29111054)
26. Nakajima, S., N. Hiramatsu, K. Hayakawa, Y. Saito, H. Kato, T. Huang, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura. 2011. Selective abrogation of BiP/GRP78 blunts activation of NF-κB through the ATF6 branch of the UPR: involvement of C/EBPb and mTOR-dependent dephosphorylation of Akt. Mol. Cell. Biol. 31: 1710-1718.
27. Du, S., N. Hiramatsu, K. Hayakawa, A. Kasai, M. Okamura, T. Huang, J. Yao, M. Takeda, I. Araki, N. Sawada, et al. 2009. Suppression of NF-κB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J. Immunol. 182: 7201-7211.
28. Shao, J., L. Qiao, R. C. Janssen, M. Pagliassotti, and J. E. Friedman. 2005. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 54: 976-984. (Pubitemid 40446311)
29. Iwawaki, T., and R. Akai. 2006. Analysis of the XBP1 splicing mechanism using endoplasmic reticulum stress-indicators. Biochem. Biophys. Res. Commun. 350: 709-715. (Pubitemid 44547905)
30. Lee, A. H., N. N. Iwakoshi, and L. H. Glimcher. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23: 7448-7459.
31. Sakurai, H., H. Miyoshi, J. Mizukami, and T. Sugita. 2000. Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1. FEBS Lett. 474: 141-145. (Pubitemid 30330823)
32. Brouard, S., L. E. Otterbein, J. Anrather, E. Tobiasch, F. H. Bach, A. M. Choi, and M. P. Soares. 2000. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192: 1015-1026.
33. Nishida, M., M. Ogushi, R. Suda, M. Toyotaka, S. Saiki, N. Kitajima, M. Nakaya, K. M. Kim, T. Ide, Y. Sato, et al. 2011. Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-κB. Proc. Natl. Acad. Sci. USA 108: 6662-6667.
34. Kitamura, M. 1997. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-β 1. J. Immunol. 159: 1404-1411. (Pubitemid 127484119)
35. Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85: 3738-3742.
36. Bezy, O., C. Elabd, O. Cochet, R. K. Petersen, K. Kristiansen, C. Dani, G. Ailhaud, and E. Z. Amri. 2005. Delta-interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding protein β, implicated in adipocyte differentiation. J. Biol. Chem. 280: 11432-11438. (Pubitemid 40418452)
37. Katayama, T., K. Imaizumi, A. Honda, T. Yoneda, T. Kudo, M. Takeda, K. Mori, R. Rozmahel, P. Fraser, P. S. George-Hyslop, and M. Tohyama. 2001. Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations. J. Biol. Chem. 276: 43446-43454.
38. Wang, X. Z., H. P. Harding, Y. Zhang, E. M. Jolicoeur, M. Kuroda, and D. Ron. 1998. Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J. 17: 5708-5717. (Pubitemid 28445982)
39. Shibahara, S., R. Müller, H. Taguchi, and T. Yoshida. 1985. Cloning and expression of cDNA for rat heme oxygenase. Proc. Natl. Acad. Sci. USA 82: 7865-7869. (Pubitemid 16169457)
40. O'Mahony, A. M., M. Montano, K. Van Beneden, L. F. Chen, and W. C. Greene. 2004. Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 279: 18137-18145. (Pubitemid 38623226)
41. Yang, F., E. Tang, K. Guan, and C. Y. Wang. 2003. IKK β plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170: 5630-5635. (Pubitemid 36617854)
42. Shimada, C., Y. Ninomiya, E. Suzuki, and K. Umezawa. 2010. Efficient cellular uptake of the novel NF-κB inhibitor (-)-DHMEQ and irreversible inhibition of NF-κB in neoplastic cells. Oncol. Res. 18: 529-535.
43. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252. (Pubitemid 27456391)
44. Wertz, I. E., and V. M. Dixit. 2010. Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2: a003350.
45. Yokouchi, M., N. Hiramatsu, K. Hayakawa, M. Okamura, S. Du, A. Kasai, Y. Takano, A. Shitamura, T. Shimada, J. Yao, and M. Kitamura. 2008. Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J. Biol. Chem. 283: 4252-4260.
46. Tagawa, Y., N. Hiramatsu, A. Kasai, K. Hayakawa, M. Okamura, J. Yao, and M. Kitamura. 2008. Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/enhancer-binding protein-homologous protein (CHOP). Free Radic. Biol. Med. 45: 50-59.
47. Kitamura, M. 2009. Biphasic, bidirectional regulation of NF-κB by endoplasmic reticulum stress. Antioxid. Redox Signal. 11: 2353-2364.
48. Rutkowski, D. T., and R. J. Kaufman. 2004. A trip to the ER: coping with stress. Trends Cell Biol. 14: 20-28. (Pubitemid 38076857)
49. Kitao, Y., K. Ozawa, M. Miyazaki, M. Tamatani, T. Kobayashi, H. Yanagi, M. Okabe, M. Ikawa, T. Yamashima, D. M. Stern, et al. 2001. Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity. J. Clin. Invest. 108: 1439-1450. (Pubitemid 33091981)
50. Nakatani, Y., H. Kaneto, D. Kawamori, K. Yoshiuchi, M. Hatazaki, T. A. Matsuoka, K. Ozawa, S. Ogawa, M. Hori, Y. Yamasaki, and M. Matsuhisa. 2005. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280: 847-851. (Pubitemid 40165054)
51. Hayakawa, K., N. Hiramatsu, M. Okamura, H. Yamazaki, S. Nakajima, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura. 2009. Acquisition of anergy to proinflammatory cytokines in nonimmune cells through endoplasmic reticulum stress response: a mechanism for subsidence of inflammation. J. Immunol. 182: 1182-1191.
52. Hayakawa, K., S. Nakajima, N. Hiramatsu, M. Okamura, T. Huang, Y. Saito, Y. Tagawa, M. Tamai, S. Takahashi, J. Yao, and M. Kitamura. 2010. ER stress depresses NF-κB activation in mesangial cells through preferential induction of C/EBP β. J. Am. Soc. Nephrol. 21: 73-81.
53. Nakajima, S., Y. Saito, S. Takahashi, N. Hiramatsu, H. Kato, H. Johno, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura. 2010. Anti-inflammatory subtilase cytotoxin up-regulates A20 through the unfolded protein response. Biochem. Biophys. Res. Commun. 397: 176-180.
54. Li, Y., E. Bevilacqua, C. B. Chiribau, M. Majumder, C. Wang, C. M. Croniger, M. D. Snider, P. F. Johnson, and M. Hatzoglou. 2008. Differential control of the CCAAT/enhancer-binding protein β (C/EBPβ) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. J. Biol. Chem. 283: 22443-22456.
55. Prösch, S., A. K. Heine, H. D. Volk, and D. H. Krüger. 2001. CCAAT/enhancer-binding proteins α and β negatively influence the capacity of tumor necrosis factor a to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor κB during monocyte differentiation. J. Biol. Chem. 276: 40712-40720.
56. Umezawa, K. 2011. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ. Biomed. Pharmacother. 65: 252-259.
57. Jahngen-Hodge, J., M. S. Obin, X. Gong, F. Shang, T. R. Nowell, Jr., J. Gong, H. Abasi, J. Blumberg, and A. Taylor. 1997. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 272: 28218-28226. (Pubitemid 27517760)
58. Obin, M., F. Shang, X. Gong, G. Handelman, J. Blumberg, and A. Taylor. 1998. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J. 12: 561-569. (Pubitemid 28183515)
59. Wu, C. J., D. B. Conze, X. Li, S. X. Ying, J. A. Hanover, and J. D. Ashwell. 2005. TNF-α induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 24: 1886-1898. (Pubitemid 40769507)
60. Zhang, L., X. Ding, J. Cui, H. Xu, J. Chen, Y. N. Gong, L. Hu, Y. Zhou, J. Ge, Q. Lu, et al. 2012. Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation. Nature 481: 204-208.
61. Mallis, R. J., J. E. Buss, and J. A. Thomas. 2001. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem. J. 355: 145-153. (Pubitemid 32304245)
62. Wang, J., E. S. Boja, W. Tan, E. Tekle, H. M. Fales, S. English, J. J. Mieyal, and P. B. Chock. 2001. Reversible glutathionylation regulates actin polymerization in A431 cells. J. Biol. Chem. 276: 47763-47766.
63. Davis, D. A., K. Dorsey, P. T. Wingfield, S. J. Stahl, J. Kaufman, H. M. Fales, and R. L. Levine. 1996. Regulation of HIV-1 protease activity through cysteine modification. Biochemistry 35: 2482-2488. (Pubitemid 26071684)
64. Klatt, P., E. P. Molina, M. G. De Lacoba, C. A. Padilla, E. Martinez-Galesteo, J. A. Barcena, and S. Lamas. 1999. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J. 13: 1481-1490. (Pubitemid 29411780)
65. Matthews, J. R., C. H. Botting, M. Panico, H. R. Morris, and R. T. Hay. 1996. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res. 24: 2236-2242. (Pubitemid 26193585)
66. Reynaert, N. L., A. van der Vliet, A. S. Guala, T. McGovern, M. Hristova, C. Pantano, N. H. Heintz, J. Heim, Y. S. Ho, D. E. Matthews, et al. 2006. Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase β. Proc. Natl. Acad. Sci. USA 103: 13086-13091. (Pubitemid 44338920)
67. Otterbein, L. E., M. P. Soares, K. Yamashita, and F. H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24: 449-455. (Pubitemid 36928103)
68. Keyse, S. M., and R. M. Tyrrell. 1989. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA 86: 99-103. (Pubitemid 19036341)
69. Wu, G., J. Marín-García, T. B. Rogers, E. G. Lakatta, and X. Long. 2004. Phosphorylation and hypoxia-induced heme oxygenase-1 gene expression in cardiomyocytes. J. Card. Fail. 10: 519-526.
70. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246.
71. Oh, G. S., H. O. Pae, B. S. Lee, B. N. Kim, J. M. Kim, H. R. Kim, S. B. Jeon, W. K. Jeon, H. J. Chae, and H. T. Chung. 2006. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic. Biol. Med. 41: 106-119.
72. Seldon, M. P., G. Silva, N. Pejanovic, R. Larsen, I. P. Gregoire, J. Filipe, J. Anrather, and M. P. Soares. 2007. Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-κB RelA phosphorylation at serine 276. J. Immunol. 179: 7840-7851.
73. 2+-ATPase of cardiac sarcoplasmic reticulum. Mol. Cell. Biochem. 248: 41-47.
74. 2+-ATPase AT submicromolar iron concentrations: evidence for metal-catalyzed oxidation. Free Radic. Biol. Med. 25: 554-560.
75. Meng, F., D. Yao, Y. Shi, J. Kabakoff, W. Wu, J. Reicher, Y. Ma, B. Moosmann, E. Masliah, S. A. Lipton, and Z. Gu. 2011. Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol. Neurodegener. 6: 34.
76. Chen, C., E. E. Dudenhausen, Y. X. Pan, C. Zhong, and M. S. Kilberg. 2004. Human CCAAT/enhancer-binding protein β gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J. Biol. Chem. 279: 27948-27956. (Pubitemid 38900063)
77. Stein, B., P. C. Cogswell, and A. S. Baldwin, Jr. 1993. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13: 3964-3974. (Pubitemid 23187624)
78. Takeiri, M., K. Horie, D. Takahashi, M. Watanabe, R. Horie, S. Simizu, and K. Umezawa. 2012. Involvement of DNA binding domain in the cellular stability and importin affinity of NF-κB component RelB. Org. Biomol. Chem. 10: 3053-3059.
79. Hu, P., Z. Han, A. D. Couvillon, R. J. Kaufman, and J. H. Exton. 2006. Autocrine tumor necrosis factor α links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and downregulation of TRAF2 expression. Mol. Cell. Biol. 26: 3071-3084.
80. Okamura, M., Y. Takano, N. Hiramatsu, K. Hayakawa, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura. 2008. Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response. Am. J. Physiol. Renal Physiol. 295: F1495-F1503. Technology